Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies

NCT ID: NCT01919957

Last Updated: 2015-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study has two purposes: firstly, a better understanding of the neurobiological processes underlying episodic memory and, secondly, the development of useful clinical applications for epileptic patients, in particular the prediction of postoperative memory deficits and the development of cognitive remediation therapies.

Memory performances during a fMRI experiment will be assessed in controls and epileptic patients before and after the surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy, Unspecified, Pharmacologically Resistant Memory Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

memory outcome

Group Type NO_INTERVENTION

No intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with drug-resistant epilepsy
* Age of 18 years or more
* Follow-up in the epilepsy unit at Pitié-Salpêtrière Hospital
* Before or after the presurgical evaluation unit including a video-EEG monitoring, a structural brain imaging and a full neuropsychological assessment
* Covered by a social security system
* Signing of consent form

Exclusion Criteria

* Persons under guardianship, curatorship or any other administrative or judicial deprivation of rights and freedom
* Refusal to consent form
* Contraindications to MRI
* Pregnancy
* Refusal to be informed in the case of detection of an abnormality during the experiment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sophie Dupont, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Service de Soins de Suites et Réadaptation Neurologique, Hôpital de la Pitié-Salpêtrière, 47/83 Bd de l'Hôpital, 75651 Paris Cedex 13

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

INSERM - Plateau IRM du CENIR, CR-ICM Hôpital Pitié-Salpêtrière, 47/83 Boulevard de l'Hôpital

Paris, Cedex 13, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sophie DUPONT, MD, PhD

Role: CONTACT

01 42 17 85 23 ext. +33

Virginie LAMBRECQ, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sophie Dupont, MD, PhD

Role: primary

01 42 17 85 23 ext. +33

Virginie Lambrecq, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A00343-42

Identifier Type: REGISTRY

Identifier Source: secondary_id

C12-11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Injury and Cognitive Function
NCT05922748 RECRUITING NA